We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice for medical professionals to follow when assessing drivers with neurological disorders.
You must tell DVLA if you've had any epileptic seizures or blackouts - download the correct form to let them know
You must tell DVLA if you have fits, seizures or convulsions - download the correct form to let them know
'Seizures of drugs in England and Wales: user guide' is designed to be a useful reference guide with explanatory notes on seizure of drugs.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine ganaxolone (Ztalmy) as the first anti-seizure medication in the UK to treat cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD).
Safety leaflet on epilepsy medicines and pregnancy to help patients and their families understanding the risks.
Contains figures for seizures of drugs made by local police forces and the UK Border Force.
Quarterly update of class A, B and C drug seizure incidents and arrests by PSNI.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.